Trademarkia Logo

United Kingdom

£
Trademark Search
SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING
Registered

on 2 Jul 2012

Last Applicant/ Owned by

SillaJen Biotherapeutics, Inc.

450 Sansome Street, 16th Floor, San Francisco, California

, , 94111

Serial Number

UK00911008992 filed on 2th Jul 2012

Registration Number

UK00911008992 registered on
10th Jan 2013

Correspondent Information

Fieldfisher LLP

IP Protection Department, 8th Floor, Riverbank House, 2 Swan Lane

London,

EC4R 3TT

SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING

pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of canc Read More

Classification Information


Class [5]
Pharmaceutical Products


Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; compounds for treating cancer; diagnostic agents for in vivo use to locate cancer sites; immunotherapeutic agents for cancer;  biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer; pharmaceutical products, drug discovery and drug delivery agents consisting of compounds for the prevention, diagnosis and treatment of cancer, namely, oncolytic virus formulations and preparations; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer.

Class [10]
Medical Instrument Products


Surgical and medical apparatus and instruments; apparatus for the treatment of cancer.

Class [42]
Computer & Software Services & Scientific Services


Scientific, biological, clinical and medical research services; medical laboratory services; conducting clinical trials; advice on scientific information relating to alleviation, diagnosis, prevention and treatment of cancer; providing scientific research information in the field of cancer research and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer.

Mark Details


Serial Number

UK00911008992

Mark Type

Word

Kind of mark

Individual